“Targeting B-Cell Receptor Signaling for Anticancer Therapy: The Bruton's Tyrosine Kinase Inhibitor Ibrutinib Induces Impressive Responses in B-Cell Malignancies” by Adrian Wiestner
Read the accompanying article: ascopubs.org/doi/full/10.1200/...
7 июн 2017